Published in Obesity and Diabetes Week, June 19th, 2006
Study 1: Probucol may suppress the progression of diabetic nephropathy.
"Probucol has antioxidant and cholesterol-lowering effects. This study examined the effect of probucol on progression of diabetic nephropathy," scientists writing in the journal Diabetes Research and Clinical Practice report.
K. Endo and colleagues at Toho University conducted "a randomized, open trial on 102 type 2 diabetes patients with clinical albuminuria (urinary albumin excretion >300 mg/g Cr). Fifty-one patients were assigned to probucol treatment (500...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.